Open access · CC-BY
via OpenAlex
Disrupted Mitochondrial and Metabolic Plasticity Underlie Comorbidity between Age-Related and Degenerative Disorders as Parkinson Disease and Type 2 Diabetes Mellitus
Diana Luz Juárez‐Flores, Mario Ezquerra, Ingrid González‐Casacuberta, Aída Ormazábal, Constanza Morén, EDUARDO S. TOLOSA, Raquel Fucho, Mariona Guitart‐Mampel, Mercedes Casado, Francesc Valldeoriola, Joan de la Torre-Lara, Esteban Muñoz, Ester Tobías, Yaroslau Compta, Francesc Josep García‐García
Antioxidants · 2020 · ▲ 24 citations
Abstract
Abstract Background. Idiopathic Parkinson’s disease (iPD) and Type 2 Diabetes Mellitus (T2DM) are chronic, degenerative, multisystemic and age-related diseases, with eventual epidemiological co-morbidity and potential overlap in molecular basis. This study aims to explore if metabolic and mitochondrial alterations underlie the suggested epidemiologic and clinical co-morbidity at molecular level. Methods. To evaluate the adaptation of iPD to a simulated pre-diabetogenic state, we exposed primary cultured fibroblasts from iPD patients and controls to standard (5mM) and high (25mM) glucose concentrations to further characterize metabolic and mitochondrial resilience.Results. iPD fibroblasts showed increased levels of organic and amino acid levels related to mitochondrial metabolism with respect to controls, and these differences were enhanced in high glucose conditions (citric, suberic and sebacic acids levels increased, as well as alanine, glutamate, aspartate, arginine and ornithine amino acids; p-values between 0.001 and p=0.05). The accumulation of metabolites in iPD fibroblasts was associated (and probably due) to the concomitant mitochondrial dysfunction(definition) observed at enzymatic, oxidative, respiratory and morphologic level. Metabolic and mitochondrial plasticity of controls was not observed in iPD fibroblasts, that were unable to adapt to different glucose conditions. Impaired metabolism and mitochondrial activity in iPD may limit energy supply for cell survival. Moreover, deficient plasticity to adapt to disrupted glucose balance characteristic of T2DM may underlay the comorbidity between both diseases. Conclusions:Fibroblasts form iPD patients showed mitochondrial impairment resulting in the accumulation of organic and amino acids related to mitochondrial metabolism, especially when exposed to high glucose condition. Mitochondrial and metabolic defects down warding cell plasticity to adapt to changing glucose bioavailability may explain the comorbidity between iPD and T2DM.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/antiox9111063
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Juárez‐Flores, D.L., Ezquerra, M., González‐Casacuberta, I., Ormazábal, A., Morén, C., TOLOSA, E.S., Fucho, R., Guitart‐Mampel, M., Casado, M., Valldeoriola, F., Torre-Lara, J.D.L., Muñoz, E., Tobías, E., Compta, Y., García‐García, F.J., García‐Ruiz, C., Fernández-Checa, J.C., Martı́, M.J., Grau, J.M., & Cardellach, F. (2020). Disrupted Mitochondrial and Metabolic Plasticity Underlie Comorbidity between Age-Related and Degenerative Disorders as Parkinson Disease and Type 2 Diabetes Mellitus. <em>Antioxidants</em>. https://doi.org/10.3390/antiox9111063
Vancouver
Juárez‐Flores DL, Ezquerra M, González‐Casacuberta I, Ormazábal A, Morén C, TOLOSA ES, et al. Disrupted Mitochondrial and Metabolic Plasticity Underlie Comorbidity between Age-Related and Degenerative Disorders as Parkinson Disease and Type 2 Diabetes Mellitus. Antioxidants. 2020. doi:10.3390/antiox9111063.
BibTeX
@article{diana2020Disrup,
title = {Disrupted Mitochondrial and Metabolic Plasticity Underlie Comorbidity between Age-Related and Degenerative Disorders as Parkinson Disease and Type 2 Diabetes Mellitus},
author = {Diana Luz Juárez‐Flores and Mario Ezquerra and Ingrid González‐Casacuberta and Aída Ormazábal and Constanza Morén and EDUARDO S. TOLOSA and Raquel Fucho and Mariona Guitart‐Mampel and Mercedes Casado and Francesc Valldeoriola and Joan de la Torre-Lara and Esteban Muñoz and Ester Tobías and Yaroslau Compta and Francesc Josep García‐García and Carmen García‐Ruiz and José Carlos Fernández-Checa and Marı́a José Martı́ and Josep M. Grau and Francesc Cardellach and Rafael Artuch and Rubén Fernández‐Santiago and Glòria Garrabou},
journal = {Antioxidants},
year = {2020},
doi = {10.3390/antiox9111063},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Aging Neuroscience 2022
Open access · CC-BY
Melatonin as an Anti-Aging Therapy for Age-Related Cardiovascular and Neurodegenerative Diseases
Brain and Behavior 2020
Open access · CC-BY
Neurodegeneration in type 2 diabetes: Alzheimer's as a case study
Journal of Gerontology and Geriatrics 2024
Open access · CC-BY
Common neurodegenerative pathways in brain aging, cognitive decline, type 2 diabetes & metabolic syndrome
International journal of molecular sciences 2026
Citation only
Exploring Pathophysiological Processes Shared Between Type 2 Diabetes Mellitus and Osteoarthritis.
PLoS ONE 2015
Open access · CC-BY
N-Glycomic Changes in Serum Proteins in Type 2 Diabetes Mellitus Correlate with Complications and with Metabolic Syndrome Parameters
Diabetes Metabolic Syndrome and Obesity 2019
Open access · CC-BY